Navigation Links
Striking a Gold Mine: H5N1 Vaccine may Serve as an Antidote for Mutants and Variants

As a breather and news that spells heaven for millions of avian influenza patients there is a research by scientists at St. Jude Children’s Research Hospital //. According to them they have developed in the lab a vaccine that is potent against one antigenic variant of the avian influenza virus H5N1. The scientific discovery is that this vaccine also has the ability to protect humans against future variants/mutants of the virus.

The great thing about such vaccines is that these can be used as stockpiles of medicine and used as and when required. This would save time and many lives unless new vaccines can be found against those variants.

A prepublication report on the study appears in the online issue of Journal of Infectious Diseases (JID).

The researchers showed that the vaccine completely protected ferrets from a lethal nasal infection against not only the original virus the vaccine was made to thwart, but also against a newer variant that has already proved fatal to humans. The ferrets experienced a more significant reduction of virus multiplication than otherwise would have occurred, the researchers reported. Moreover, the infections failed to spread out of the upper respiratory tract to the lungs or brain.

“These findings are especially significant because ferrets are known to be an excellent and accurate model of influenza infection and immune response in humans,” said Elena Govorkova, Ph.D., a staff scientist in the Department of Infectious Diseases at St. Jude. “Restricting the infection to the upper respiratory tract is important since in humans the virus has been isolated from specimens taken from the cerebrospinal fluid, feces, throat and blood serum. Therefore, limiting the spread of virus in an infected human is crucial to saving that person’s life.” Govorkova is the lead author of the JID paper and led the research team conducting the study.

The team also showed that the optimal strategy for vaccinatio n of immunologically na?ve individuals will be the use of two doses, which in the ferrets triggered more antibody protection than a single dose. Immunologically na?ve individuals are those whose immune systems have not been stimulated to respond to a particular antigen.

The St. Jude study was the first one to show cross-reactive immunity against current H5N1 variants in ferrets, according to Robert Webster, Ph.D., a member of the Infectious Diseases department and holder of the Rose Marie Thomas Chair at St. Jude. Webster is an internationally renowned expert on avian influenza viruses and is senior author of the report in JID.

Cross-reactive immunity is the protection that a virus vaccine confers against not only the same virus, but also against variants of the original virus. “Such cross-protection would allow the use of a stockpiled vaccine until a vaccine against the specific variant causing the outbreak is developed,” Webster said. “So our success with ferrets is extremely promising news.”

Using reverse genetics, the team mixed genes from a safe, laboratory bird flu virus with a gene for the hemagglutinin (HA) protein from the H5N1 virus isolated in Hong Kong. The virus uses the HA proteins on its surface to infect cells in the respiratory tract. The resulting vaccine had the outside appearance of a dangerous virus that would stimulate the immune system, but the inside genes of a harmless variety of virus that could not cause disease. The St. Jude team was the first to use reverse genetics to make a vaccine against H5N1 that moved out of the laboratory and into clinical trials.

(Source: Nwswise)
'"/>




Related medicine news :

1. Signature Campaign: Striking doctors take to the streets
2. Striking Doctors Urged By AP High Court To End Strike
3. Striking Doctors Form Human Chain, Block Traffic
4. Striking Students Asked to Vacate Hostels
5. President Kalam Meets Striking Medicos However Stir to Continue
6. Supreme Court Verdict Gives Hope to Striking Medicos
7. President Kalam Meets Striking Medicos However Stir to Continue
8. Supreme Court Verdict Gives Hope to Striking Medicos
9. Ramadoss Examines Patients At AIIMS, Warns Striking Doctors
10. Supreme Court Orders Striking Medicos To Call Off Agitation Immediate
11. No Punitive Action Against Striking Medicos if Strike Called Off
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2018)... , ... September 21, 2018 , ... Located on the ... open its new inpatient hospice unit on Monday, October 1. The 8,500 square-foot unit ... , “We are excited to partner with an organization like TGH that provides excellent, ...
(Date:9/15/2018)... NEW ORLEANS (PRWEB) , ... September 14, 2018 ... ... solutions for the behavioral healthcare industry, announced its live training initiative, "ShareNote Live" ... full understanding of how they can maximize its existing features and functionality in ...
(Date:9/13/2018)... ... , ... The Kelly Foundation awarded $83,000 to Saint John’s ... and children experiencing homelessness in the Sacramento region. The donation will go towards the ... of Saint John’s open after the County of Sacramento decided not to renew its ...
(Date:9/12/2018)... ... ... Definitive Healthcare , the leading provider of data, intelligence, and analytics ... Cancer Institute and the Jimmy Fund. , “It’s a really fun day in ... have such wonderful sponsors and volunteers. The growth we’ve seen over past two years ...
(Date:9/7/2018)... ... ... Start your engines and race to the new Riley Children’s Health Sports Legends ... the name of the game here – whether it’s flying straight forward on Church ... Speedway oval. , The timing couldn’t be better with a few of the nation’s ...
Breaking Medicine News(10 mins):
(Date:9/13/2018)... ... September 13, 2018 , ... Becker's Healthcare is ... , Hospitals and health systems rely on CIOs and IT department leaders to ... data-gathering and cybersecurity initiatives. Those who lead community hospital and health system IT ...
(Date:9/12/2018)... ... September 13, 2018 , ... Safety Reporting in Global ... — 1:30 p.m. – 3:00 p.m. ET, http://info.fdanews.com/safety-reporting-in-global-clinical-trials , Clinical research ... as fifty percent. , This can be due to a lack of ...
(Date:9/7/2018)... ... September 07, 2018 , ... Elaine Uonelli, a ... a gripping narrative that shows the author’s experience of encountering with Burkitt lymphoma—an ... writes an eventful life that revolves around a disease with a lasting impact ...
Breaking Medicine Technology: